SUBSEQUENT EVENTS	6 Months Ended
Mar. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 9 – SUBSEQUENT EVENTS Subsequent to March 31, 2022, the Company borrowed $150,000 from its officers and shareholders. All of the loans are unsecured, have an interest rate of eight percent and are due one year from the date of issuance. On April 1, 2022, the Company’s Board of Directors approved the issuance of a combined total of 3,750,000 restricted shares of the Company’s common stock to certain of its Officers and Directors for future services to be performed. The shares vest monthly from April 2022 through March 2025. The fair value of the shares on the date of grant was $187,500. The Board also approved the issuance of a combined total of 7,060,000 restricted shares of the Company’s common stock to certain of its Officers and Directors in connection with their officer and shareholder loans. The shares vested upon grant and had a fair value on the date of grant of $353,000. These shares were granted from the 41,353,731 deferred restricted shares of the Company’s common stock which will only be issued upon the sale or merger of the Company (see Note 6 – Restricted Stock Grants), thus reducing the number of shares that can be issued under that certain condition. During the year ended September 30, 2021, the Company entered into an agreement with a consulting firm under which the firm would provide certain services for the Company. Under the agreement, the firm could earn 1.0 million restricted shares of the Company’s common stock for completing certain services. In April 2022, the Company’s Board of Directors approved the issuance of the 1.0 million shares once the services had been completed. The shares vested upon grant and had a fair value on the date of grant of $50,000.

SUBSEQUENT EVENTS

6 Months Ended

Mar. 31, 2022

NOTE 9 – SUBSEQUENT EVENTS

Subsequent to March 31, 2022, the Company borrowed $150,000 from its officers and shareholders. All of the loans are unsecured, have an interest rate of eight percent and are due one year from the date of issuance.

On April 1, 2022, the Company’s Board of Directors approved the issuance of a combined total of 3,750,000 restricted shares of the Company’s common stock to certain of its Officers and Directors for future services to be performed. The shares vest monthly from April 2022 through March 2025. The fair value of the shares on the date of grant was $187,500.

The Board also approved the issuance of a combined total of 7,060,000 restricted shares of the Company’s common stock to certain of its Officers and Directors in connection with their officer and shareholder loans. The shares vested upon grant and had a fair value on the date of grant of $353,000. These shares were granted from the 41,353,731 deferred restricted shares of the Company’s common stock which will only be issued upon the sale or merger of the Company (see Note 6 – Restricted Stock Grants), thus reducing the number of shares that can be issued under that certain condition.

During the year ended September 30, 2021, the Company entered into an agreement with a consulting firm under which the firm would provide certain services for the Company. Under the agreement, the firm could earn 1.0 million restricted shares of the Company’s common stock for completing certain services. In April 2022, the Company’s Board of Directors approved the issuance of the 1.0 million shares once the services had been completed. The shares vested upon grant and had a fair value on the date of grant of $50,000.

Wellness Center USA, Inc. 10-Q